Första AP-fonden’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.83M | Buy |
33,200
+1,500
| +5% | +$82.5K | 0.01% | 532 |
|
|
2025
Q1 | $2.24M | Sell |
31,700
-4,700
| -13% | -$332K | 0.02% | 521 |
|
|
2024
Q4 | $2.39M | Hold |
36,400
| – | – | 0.02% | 531 |
|
|
2024
Q3 | $2.56M | Buy |
36,400
+3,400
| +10% | +$239K | 0.02% | 518 |
|
|
2024
Q2 | $2.72M | Sell |
33,000
-3,300
| -9% | -$272K | 0.02% | 478 |
|
|
2024
Q1 | $3.17M | Buy |
36,300
+4,000
| +12% | +$349K | 0.03% | 486 |
|
|
2023
Q4 | $3.11M | Sell |
32,300
-5,200
| -14% | -$501K | 0.03% | 466 |
|
|
2023
Q3 | $3.32M | Buy |
37,500
+700
| +2% | +$61.9K | 0.04% | 436 |
|
|
2023
Q2 | $3.19M | Sell |
36,800
-400
| -1% | -$34.7K | 0.03% | 460 |
|
|
2023
Q1 | $3.62M | Sell |
37,200
-6,000
| -14% | -$583K | 0.04% | 416 |
|
|
2022
Q4 | $4.47M | Buy |
43,200
+8,400
| +24% | +$869K | 0.05% | 393 |
|
|
2022
Q3 | $2.95M | Buy |
34,800
+10,100
| +41% | +$856K | 0.04% | 445 |
|
|
2022
Q2 | $2.05M | Sell |
24,700
-43,800
| -64% | -$3.63M | 0.03% | 504 |
|
|
2022
Q1 | $5.28M | Buy |
68,500
+57,200
| +506% | +$4.41M | 0.06% | 355 |
|
|
2021
Q4 | $998K | Sell |
11,300
-29,700
| -72% | -$2.62M | 0.01% | 526 |
|
|
2021
Q3 | $3.17M | Sell |
41,000
-32,900
| -45% | -$2.54M | 0.04% | 462 |
|
|
2021
Q2 | $6.17M | Buy |
73,900
+6,000
| +9% | +$501K | 0.07% | 334 |
|
|
2021
Q1 | $5.13M | Buy |
67,900
+34,200
| +101% | +$2.58M | 0.07% | 334 |
|
|
2020
Q4 | $2.96M | Sell |
33,700
-3,600
| -10% | -$316K | 0.04% | 432 |
|
|
2020
Q3 | $2.84M | Buy |
37,300
+9,300
| +33% | +$708K | 0.06% | 358 |
|
|
2020
Q2 | $3.45M | Buy |
28,000
+2,000
| +8% | +$247K | 0.09% | 243 |
|
|
2020
Q1 | $2.2M | Buy |
+26,000
| New | +$2.2M | 0.08% | 297 |
|